PTCT
PTC THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$68.97
+1.25%Next report
Analyst consensus
- Next report date
- Feb 18, 2027
- EPS estimate
- $0.35
- Revenue estimate
- $330.4M
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- -$0.62
- EPS estimate
- $0.14
- Revenue actual
- $357.8M
- Revenue estimate
- $306.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -211.2%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $109
- PT range
- $77 – $137
- Analysts
- 6
5 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | $0.14 | -$0.62 | Miss -532.36% | $357.8M |
| Jul 30, 2026 | $0.24 | $0.92 | Beat 289.34% | $360.5M |
| May 7, 2026 | -$0.45 | -$0.03 | Beat 93.33% | $272.6M |
| Feb 19, 2026 | -$0.21 | -$1.67 | Miss -695.24% | $164.7M |
| Nov 4, 2025 | -$1.19 | $0.20 | Beat 116.81% | $211.0M |
| Aug 7, 2025 | -$1.07 | -$0.83 | Beat 22.43% | $178.9M |
| Feb 27, 2025 | -$1.12 | -$0.24 | Beat 78.57% | $213.2M |
| Nov 7, 2024 | -$1.54 | -$1.39 | Beat 9.74% | $196.8M |
| Aug 8, 2024 | -$1.00 | -$1.16 | Miss -16.00% | $186.7M |
| Apr 25, 2024 | -$1.21 | -$1.20 | Beat 0.83% | $210.1M |
| Feb 29, 2024 | $0.29 | -$0.24 | Miss -182.76% | $307.1M |
| Oct 26, 2023 | -$0.85 | -$1.76 | Miss -107.06% | $196.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 18, 2027